Fact CheckerSign in

NCT06799104Not yet recruiting

EFFECT OF PYRAMIDAL TRAINING ON EPICARDIAL FAT FOR CORONARY ARTERY DISEASE PREVENTION

Source: ClinicalTrials.gov · Last updated 6 Feb 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

To show the effect of pyramidal training for coronary artery disease prevention on: -Epicardial fat, BMI, Waist circumference (WC), Lipid profile, Quality of life and Mediterranean Diet Adherence.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
50 (estimated)
First submitted
23 Jan 2025
Start date
Feb 2025
Primary completion date
Jan 2026
Lead sponsor
Cairo University
NCT number
NCT06799104

What you commit to

  • Study type: Interventional
  • Planned participants: 50
  • From Feb 2025 to the primary completion date, Jan 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patients with conditions will be excluded such as:
    • Musculoskeletal problems.
    • Chronic pulmonary disease.
    • Missed more than two weeks of the program or want to terminate the program.
    • Unstable angina.
    • Acute illness.
    • Uncontrolled cardiac arrhythmia.
    • Decompensated heart failure.
    • Cognitive impairment or mental disorders.
    • Systolic blood pressure higher than 180, and/or diastolic blood pressure over 100mmHg.
    • DVT.
    • Multiple food allergies/intolerances or gastrointestinal difficulties of the prescribed diet.
    • Cancer (have special nutritional and training needs).

Who the study is looking for

  • Fifty females' patients with class I obesity (BMI 30 to 34.9 kg/m2, Waist circumference \> 88 cm).
    • Their age ranges from 30-40 years old.
    • Dyslipidemia and lipid profile as follow (total cholesterol high: 240 mg/dl, HDL less than 40 mg/dl, LDL high: 160-189 mg/dL and triglycerides high: 200-499 mg/dl).
    • All patients will be clinically and medically stable when attending the study.

Age in the registry: 30 years to 40 years · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Cairo University
Coordinator of this site? Confirm its status
CairoEgyptUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.